Psoriasis (Human)(1 expert discussions analyzed)
Most people with psoriasis are told it is a skin disease — but one functional medicine physician argues the plaques on your skin may be the last stop on a journey that starts in your gut, raising an uncomfortable question: if the root cause is systemic inflammation originating elsewhere in the body, why are almost all standard treatments aimed only at the skin?
First synthesised Apr 19, 2026·Last reviewed Apr 19, 2026
What matters
Primary Topic Intent
This page helps readers understand whether gut health, dietary triggers, and hidden infections may be contributing to their psoriasis, and how to evaluate that possibility alongside — not instead of — conventional treatment.
Psoriasis is already recognized by mainstream medicine as a systemic inflammatory disease, not merely a skin condition. People with psoriasis have measurably higher rates of cardiovascular disease, psoriatic arthritis, inflammatory bowel disease, and depression. This matters because it means the inflammation driving the visible plaques is also circulating through the rest of the body — and treating only the skin surface leaves those broader risks unaddressed.
The central argument presented by Dr. Greenberg in the source episode is that gut inflammation may be a significant upstream driver of psoriasis for at least some patients. The proposed mechanism involves increased intestinal permeability — sometimes called 'leaky gut' — in which the gut lining becomes less effective as a barrier. When bacterial fragments pass through into the bloodstream, the immune system mounts a response. That immune response may accelerate the rate at which skin cells multiply and accumulate, producing the thick, red, scaly plaques characteristic of psoriasis. This is a biologically plausible mechanism, but it has not yet been confirmed in large human trials specifically for psoriasis.
Three specific triggers are highlighted as recurring patterns in clinical cases: streptococcal throat infections (particularly associated with guttate psoriasis, the small drop-shaped variant), mold exposure from water-damaged buildings, and gluten sensitivity. The episode notes that some patients report meaningful skin improvement after eliminating gluten, while others see no change — suggesting these triggers are highly individual rather than universal. The honest implication is that trigger identification requires personal experimentation, not a one-size-fits-all protocol.
The episode also raises a pointed question about biologics — the powerful immune-modulating drugs that are currently the standard of care for moderate to severe psoriasis. Biologics are effective at suppressing the inflammatory signal, but the episode's position is that they may not address whatever is generating that signal in the first place. Clinical cases are cited in which trigger removal reduced patients' dependence on medication, but this is observational clinical experience, not controlled trial data. Readers should understand that biologics have a strong evidence base and should not be discontinued without medical supervision.
Best-supported action
A structured elimination is the most practical starting point for identifying dietary triggers — but what you learn from it depends heavily on your type of psoriasis. In some cases, dietary triggers are the primary driver, and elimination produces visible clearing within weeks. In others, psoriasis is being sustained by gut permeability, infection triggers, or immune dysfunction that dietary change alone cannot fully address. Running the elimination without tracking the right variables can mean either missing a real trigger or concluding that diet doesn’t matter when the protocol simply wasn’t long enough or strict enough.
Limits and unknowns
Understand where experts converge, where they differ, and what remains uncertain.
The entire evidence base for this topic comes from one clinician's podcast episode drawing on clinical case experience — there are no randomized controlled trials cited linking gut-targeted interventions to measurable psoriasis improvement in large human populations.
The reliability and clinical utility of the specific tests recommended — comprehensive stool microbiome panels and urinary mold toxin tests — for guiding psoriasis treatment has not been established in peer-reviewed dermatology research.
Dietary interventions (gluten elimination, dairy elimination, nightshade elimination) show highly variable results across individuals. The episode acknowledges that some patients see no improvement from dietary changes, meaning there is no way to predict in advance whether this approach will work for any given person.
The episode does not address how gut-targeted approaches compare head-to-head with biologics in terms of efficacy, speed of response, or safety for moderate to severe psoriasis — a critical gap for anyone making treatment decisions.
The concept of 'leaky gut' as a driver of psoriasis, while biologically plausible, remains an area of active research rather than established clinical fact. The mainstream dermatology community does not yet endorse gut permeability testing or gut-targeted treatment as standard psoriasis care.
Episodes
This topic is based on 1 expert episode totalling 59 minutes of content.
Explore the full synthesis
Our editorial synthesis identified:
The full synthesis unlocks:
- Expert Deep Dive audio: the complete synthesis across all expert discussions
- Full ranked strategy list
- Emerging strategies worth watching
- Which approaches fit different situations
- Health models and cross-topic connections
- Doctor preparation and a printable summary